To date a number of studies have evaluated hENT1 and other factors involved in gemcitabine pathway by means of functional assays in pancreatic cancer cell lines and/or human specimens mainly by using immunoistochemistry, and transcriptional analysis in few cases [24-28]. This evidence concerns the gene SLC29A1 and familial pancreatic carcinoma.